INTRODUCTION
L-Glutamic acid is the major excitatory neurotransmitter in the mammalian brain (Fonnum, 1984; Nicholls, 1989; Maycox et al., 1990; McMahon and Nicholls, 1991) . It plays a predominant role in integrated brain function, and a growing body of evidence suggests that it is involved in the development of irreversible injury in a number of disorders causing neuronal degeneration (Rothman and Olney, 1987; Choi, 1990) . Thus the metabolism, release and uptake of glutamate have been targets of extensive neurochemical research. The development of water-suppressed 'H n.m.r. has made it possible to measure glutamate nondestructively in vivo. Previous studies have indicated that 'H n.m.r. does not detect all of the biochemically assayed brain glutamate (de Graaf and Bovee, 1990; Kauppinen and Williams, 1991; Pirttila et al., 1993) . It has been concluded that as much as 30 % of cerebrocortical glutamate does not contribute to the C-4 peak of glutamate at 2.35 p.p.m. in animal brain (Kauppinen and Williams, 1991; Pirttila et al., 1993) . Data from clinical 'Hn.m.r. spectroscopy have indicated that glutamate in human brain quantified by this means may be less than that determined by biochemical methods (Michaelis et al., 1993) . This peak is well resolved in the brain 'H-n.m.r. spectrum collected either at high field (> 7 T) or at low field (approx. 1.5 T) using short echo times (approx. 20 ms) (Frahm et al., 1990) . The recent demonstration that tricarboxylic acid-cycle activity can be estimated non-invasively in brain from 'H-n.m.r. measurements of glutamate enrichment with '3C label (Fitzpatrick et al., 1990) emphasizes the importance of understanding the n.m.r. visibility of glutamate.
It has been suggested that the partial 'H-n.m.r. invisibility of glutamate may be caused by its distribution between neurons and glia (de Graaf and Bovee, 1990) . We have previously used the superfused brain slice preparation as a model of cerebral cortex in order to study glutamate metabolism non-destructively by n.m.r. (Kauppinen and Williams, 1991; Pirttila et al., 1993) . Our tively. In contrast, lactate C-3 reached a steady-state fractional enrichment ofapprox. 43 % by 15 min and there was no difference between the values determined in the slice preparations and the acid extracts. There was a significant difference between the glutamate C-4 fractional enrichments in the brain slices (7.4 + 0.6 %) and extracts (5.1 + 0.3 %) after 60 min of incubation with [2-13C]acetate. Thus 13C label from both glucose and exogenous acetate enters a pool of glutamate that is more amenable to 'H n.m.r. detection than total acid-extracted brain biochemical glutamate, whereas lactate is labelled with full 'H n.m.r. visibility. The results are discussed in the light of the biochemical factors that affect glutamate 'H-n.m.r. susceptibility and thus its n.m.r. visibility. data showed that, under controlled bioenergetic conditions, 75 0 of brain glutamate is 'H-n.m.r. visible (Pirttila et al., 1993) . Both severe energy failure and challenge with a K+/H+ ionophore, nigericin, without complete collapse of ATP caused all of the glutamate to become detectable by 'H n.m.r. (Pirttila et al., 1993) . These observations lend support to the idea that 'H-n.m.r. invisibility of glutamate may be due to subcellular compartmentation. In order to explore this hypothesis, we have studied n.m.r. detectability of newly synthesized ['3C]glutamate from either exogenous glucose or acetate in a superfused brain slice preparation by using 'H n.m.r. specifically designed to detect the fractional enrichment of '3C-labelled metabolites.
EXPERIMENTAL
Preparation of cerebral brain slices, Incubations and n.m.r. methods Transverse cortical brain slices (thickness 0.35 mm) from male guinea pigs (250-400 g, Dunkin-Hartley strain) were prepared and superfused as described previously (Cox et al., 1983) . The cerebral slices were initially incubated in Krebs-Henseleit buffer containing 124 mM NaCl, 5 mM KCI, 1.2 mM MgSO4, 1.2 mM CaCl2, 26 mM NaHCO3, 1.2 mM KH2FPO4 and 5 mM D-glucose equilibrated with 02/CO2 (95 %/5 %, v/v) for 30-45 min at 37 'C. Medium phosphate was omitted in order to monitor and utilize the intracellular Pi as an indicator of pHi (Taylor et al., 1983 ) using 31P n.m.r. In labelling experiments, 5 mM D-glucose in the superfusion medium was replaced by either 5 mM D-[1-_3C]glucose or 5 mM [2-'3C]acetate and 2.5 mM D-glucose.
3'P-n.m.r. spectra were recorded using a Bruker 15 mm IH/ broad-band (tuned to 31P at 162.0 MHz) n.m.r. probe in a 9.4 T vertical magnet interfaced with a Bruker AM400 spectrometer as previously described (Pirttila et al., 1993) . 'H-n.m.r. spectra [spectral width 5 kHz, 4096 data points, interpulse interval 1.7 s, with optimum excitation adjusted at 2.02 p.p.m. (Hore, 1983;  Abbreviations used: NAA, N-acetylaspartate; PCA, perchloric acid; pHi, § To whom correspondence should be addressed. intracellular pH; TE, spin-echo time; T2, spin-spin relaxation decay. Williams et al., 1988) and spin-echo time, TE = 120 ms] were recorded using the following spin-echo sequence incorporating solvent suppression pulses:
(1-3-3-1)-(TE/2)-(2--6-2)-(TE/2)-acquire (1) 'H-n.m.r. spectra were processed and peak areas determined using a line-fitting routine (Glinfit, Abacous Spectrospin Co.) as previously described (Pirttila et al., 1993) . Chemical shifts are expressed relative to a value of 2.02 p.p.m. for the methyl resonance of N-acetylaspartate (NAA).
The detection of protons bonded to 13C carbons was accomplished by exploiting the spin-spin coupling between directly bonded 'H and 13C nuclei, based on the method described by Rothman and co-workers (Rothman et al., 1985) . In these experiments the broad-band channel was returned to the 13C frequency (100.6 MHz), and used to deliver composite 13C inversion pulses with phase cycling as previously described (Tycko et al., 1985) . These pulses were incorporated into the binomial spin-echo sequence above on alternate scans, 3.9 ms after the excitation pulse train as follows:
peaks are referenced to 3-[2H](trimethylsilyl)propionic acid at 0 p.p.m., which was also used as a concentration standard.
Proton-decoupled 13C-n.m.r. spectra (interpulse interval 6.5 s, spectral width 11.6 kHz, 32768 data points) were (Kapetanovic et al., 1990) . Briefly, the residues were derivatized with 200,u of acetonitrile/N-methyl-N(t-butyldimethylsilyl)trifluoroacetamide (3: 1, v/v) at 80°C for 30 min. The derivatives of amino acids were separated on a capillary column (DB-5 25 m, internal diameter 0.20 mm, pore size 'H
(1-3-3-1)---60 ms---(2-6--2)---60 ms---acquire 13C 3.9 ms--1800°-The 3.9 ms delay equals 1/(2J) for the 'H/'3C coupling ((HC) = 127 Hz) and allows the 'H/'3C doublet to precess into antiphase so that, in the presence of inversion pulse, the signal from '3C-bonded protons is inverted relative to that of 12C-bonded protons. Subtraction of the two subspectra yields the 13C satellite resonances of protons bonded to 13C. Decoupling at the '3C frequency was not used during acquisition. The subtraction artifact obtained by the present method in phantoms was less than 1 % and thus could be ignored. (1 vol.) were homogenized in 0.9 M ice-cold perchloric acid (PCA) (3 vol.) using a Potter-Elvehjem homogenizer as previously described (Kauppinen and Williams, 1991 12.9, 12.6, 12.6 and 12.9 % in spectra recorded using intervals of 1.5, 5, 10 and 25 s respectively. High-resolution 'H/'3C correlation n.m.r. spectra via zero and double quantum coherence without decoupling during acquisition (spectral width 4 kHz, 16384 data points, interpulse interval of 7.1 s, optimized for J(HC) = 127 Hz) were collected using a dedicated 5 mm inverse 13C probe (Bruker, Rheinestetten, Germany) (see Bax and Subramanian, 1986) .
Some metabolites were quantified in absolute terms by 'H n.m.r. Fully relaxed spectra were acquired using 900 repeated every 7.1 s (spectral width 4 kHz, 16384 data points) with lowpower presaturation of the residua-l 2H signal. Chemical shifts of (2) ( 3) --acquire 0.11utm; J&W Scientific, Folsom, CA, U.S.A.) in an HP 5890 gas chromatograph, and the individual compounds were analysed in a VG Trio-2 quadrupole mass spectrometer (VG Masslab; Manchester, U.K.) in an electron ionization mode. Gaschromatography oven-temperature profile was as follows: hold 0.5 min at 50°C, program 20°C/min to 180°C, program 18°C/min to 270°C respectively, ionization chamber set at 200 'C. This provided an adequate separation of glutamate (retention time of 12.7 min) from other acid-extractable metabolites. Selected ion recording was used for determination of ion abundances. The prominent and characteristic [M-57]+ ions were monitored for glutamate (m/z 432) and for its M+ 1 isotope (m/z 433). Stable isotope enrichment was calculated by making first-order corrections (for natural abundance). in the slice preparations. Fractional enrichments in brain slices calculated from spectra using spin-echo delays of 5 and 60 ms were similar within experimental error (24.2 % compared with 23.7% respectively, n = 2). This indicates that the spin-spin Figure 1 1H-n.m.r. and 1H-detected/13C-edited n.m.r. spectra of a superfused brain slice preparation and an acid extract Cortical brain slices were superfused and 1H-n.m.r. and 1H-detected/13C-edited n.m.r. spectra acquired as described in the Experimental section. In (a) superfusion medium contained 5 mM Dglucose as substrate and sequence (1) was used. Peaks are assigned as follows: 1, glucose; 2, glucose+choline-containing compounds; 3, creatine+phosphocreatine; 4, aspartate+NAA; 5, glutamine+ NAA; 6, glutamate; 7, NM; 8, lactate. The spectra in (b) and (c) were collected after 56 min superfusion with 5 mM [1-13C]glucose, and the 1H-detected/13C-edited n.m.r. sequence (2) was used for the spectrum (b) and sequence (3) for the spectrum (c). (a-c) are sums of 128 scans each. (d) is the difference spectrum of (b)-(c) and it consists of 256 scans and is 8-fold magnified relative to (b). The spectra (e) and (f) (512 scans each) are from an extract of a preparation after 100 min superfusion in the presence of 5 mM [1 -13C]glucose; they were collected using sequence (2) and (3) respectively. (g) is the difference spectrum of (e)-(1) and is 8-fold magnified relative to (e). The spectrum (h) is a high-resolution 1H/13C edited spectrum of the same extract. Satellite resonances from glutamate C-4 (V), glutamate C-3 (0) and lactate C-3 (*) are indicated.
relaxation times (T2) of 12C-and '3C-bonded protons were not significantly different. Therefore the fractional enrichments of metabolites in the brain slices do not require correction for the spin-spin relaxation. The edited spectrum of an extract (Figure ig) shows the satellites of glutamate C-4 and lactate C-3 with similar relative intensities to those detected in the slice preparation ( Figure Id) . A high-resolution 1H/'3C correlation spectrum of the same extract (Figure lh) Figure 2 . The satellites of both glutamate C-4 and lactate C-3 in the brain slices were detectable after 4 min incubation with labelled glucose ( Figure   2 ). Owing to non-uniform excitation of the 1-3-3-1 pulse train, the downfield satellite (at 1.17 p.p.m.) is barely visible. In the subsequent quantification, only the peak at 1.49 p.p.m. was used for estimation of lactate C-3 enrichment. It should be noted that we did not detect consistently satellites of glutamate C-3 ( Figure  hd) , presumably because of its low fractional enrichment relative to C-4 (see below). The increase in the fractional 13C enrichment of glutamate C-4 ( Figure 3a) (Figure 3a) which matched well the reduction of 12C-4 relative to NAA by 23.8 + 3.9% (Figure 3b ). Lactate C-3 reached a steady-state enrichment of 43 + 4% after 15 min of superfusion under the same conditions. These maximum fractional enrichments of glutamate C-4 and lactate C-3 are in line with previous observations (Badar-Goffer et al., 1990 (Figure 2 ). The fractional enrichment from glucose of glutamate C-4 determined in the acid-extracted brain slices was significantly less than that measured in cerebral cortex throughout the observation period of 100 min. At 4 min of superfusion with [1-13C] glucose, the enrichment of glutamate C-4 in the brain slices was 5.2 + 0.3 %, which was as much as the labelling of C-4 in the tissue extracts (4.0 0.7 %) at 10 min (Figure 3a) . At 30 min of incubation, the fractional enrichment of glutamate C-4 in the extracts was 10.6+0.94% and at 100 min 19.7+0.37o%, corresponding to 58.2 % and 80.4 % respectively of that determined in the slice preparations. Thus the labelling of the acid-extracted (total biochemical) pool of glutamate was less at all time points than that determined in slices. Lactate C-3 labelling in the brain slices did not differ from that determined in their acid extracts at any time point analysed (Figure 3c concentration was also constant. Glutamate/NAA and NAA concentrations in the extracts also did not change during the course of the experiments (Table 1) . Glutamate labelling in tissue acid extracts (M+ 1) was also determined by m.s. These data are shown together with glutamate C-4 enrichment assayed by n.m.r. in Figure 4 (a). The labelling of glutamate determined by m.s. was approx. 30 % greater at all time points analysed than that found in C-4 by n.m.r. The proton-decoupled 13C-n.m.r. spectrum of acid extracts from preparations superfused in the presence of [1-"C]glucose revealed label in glutamate (C-2, C-4 and C-3), lactate (C-3), acetate and y-aminobutyrate (C-2, C-3). This is in accord with published data on 13C labelling both in brain slices (Badar-Goffer et al., 1990 and in vivo (Rothman et al., 1985; Fitzpatrick et al., 1990) . From these extract spectra, we calculate that the glutamate C-4 peak contained 71 +4 and 68 +4 % of the total glutamate 13C label at 10 and 100 min incubation times respectively. The glutamate C-3 contained 15 + 30% and 17±1 0% and the C-2 14+1% and 16+3 % of the total label at 10 and 100min. On the basis of these data we ascribe the difference between m.s. and n.m.r. results (Figure 4a ) to the labelling of glutamate C-2 and C-3. The conclusion is consistent with earlier work on 13C-labelling of brain slices (Badar-Goffer et al., 1990). Fractional enrichments of glutamate C-4 (a) and lactate C-3 (c) were determined in both the slice preparations (filled symbols) and extracts (open symbols) using n.m.r. as described in the Experimental section. Glutamate/NAA peak area ratios were calculated from the 1 H-detected/13C-edited n.m.r. subspectra without 13C composite pulses [sequence (2) than that (5.1+0.34%, P < 0.01, Student's t test) determined in the extracts. Glutamate enrichment (M+ 1) measured by m.s. was 6.9 + 0.1 and 8.9 0.3 % at 30 and 60 min respectively (Figure 4b ). Proton-decoupled 13C n.m.r. of the extracts revealed that 72 + 6 % of glutamate label was in C-4, 8 4 % in C-3 and 20 3 % in C-2. Phosphocreatine/,8-ATP and pH, in the slice preparations and glutamate/NAA ratios and NAA concentrations in their extracts were unchanged after 60 min of superfusion with acetate-containing medium (Table 1) .
DISCUSSION
The present results demonstrate the superiority of indirect detection of 13C label by 'H n.m.r. for following labelling as it happens, non-destructively, and also show that the technique gives data from tissue acid extracts which is in agreement with a previous report (Badar-Goffer et al., 1990) . We have addressed the 'H-n.m.r. detectability of both newly synthesized glutamate and lactate, the concentrations of which were sufficiently high to allow their fractional enrichments to be compared in both brain slices and extracts. It is evident that there are significant differences between the 'H-n.m.r. detectability of these two metabolites. Our data provide evidence concerning the metabolic compartmentation of brain glutamate and the influence of this on the compound's 'H-n.m.r. visibility, which will need to be taken into account when interpreting labelling patterns in vivo. The use of spin echo improves water suppression and simplifies cerebral 'H-n.m.r. spectra by reducing the contribution of short T2 components from macromolecular species (Behar and Ogino, 1991; Kauppinen et al., 1992) . However, signal amplitudes vary as a function of echo time as a result of: (i) intrinsic (spin-spin) relaxation processes; (ii) molecular diffusion in the presence of intracellular magnetic-field gradients (Brindle et al., 1979) ; and (iii) homonuclear spin-spin coupling. Factors (i) and (ii) may vary in different cellular and subcellular compartments, and contribute to differential n.m.r. visibility for given compounds. Our data for lactate indicate that the n.m.r. visibility of newly synthesized [3-_3C] lactate is the same as that of ['2C]lactate. Furthermore, on the basis of the very similar lactate/NAA ratio in slices and extracts, we conclude that spin-echo 'H n.m.r. detects 100 % of intracellular lactate. The T2 value of lactate CH3 under control conditions is approx. 100 ms, which is similar to that of NAA at 2.02 p.p.m. (Kauppinen and Williams, 1991) . We have previously shown that these two compounds have similar T2 values and saturation factors in superfused slices so that no correction to the ratio in slices is necessary (Kauppinen and Williams, 1991) . A similar conclusion was drawn in a quantitative 'H-n.m.r. study of brain in vivo where NAA was also shown to be fully detectable by 'H n.m.r. (Williams et al., 1988) . Therefore it appears that intracellular magnetic-field gradients and molecular diffusion affect the signal intensities of these metabolites equally in slice preparations. There is no evidence for subcellular compartmentation of either NAA or lactate, although it should be remembered that NAA is considered to be solely a neuronal metabolite (Urenjak et al., 1992) . The issue of glutamate 'H-n.m.r. detectability is more complex than that of lactate or NAA, for reasons relating to both n.m.r. and biochemistry. Strong spin-spin coupling of the non-equivalent C-4 protons to each other and to the C-3 protons makes it impossible to determine glutamate T2 in slices using the sequences we have employed. We have assumed that glutamate has the same T2 as lactate, NAA and creatine, all of which we have measured and shown to be not significantly different (Kauppinen and Williams, 1991) . If our assumption were wrong, then the quantification relative to NAA would be wrong (i.e. our estimate of glutamate invisibility would be in error), but the fractional enrichment calculations would still be correct (we have shown that the T2 of 12C-and 13C-bonded protons cannot be very different in brain slices). As the differences in fractional enrichment between slices and extracts can only be explained on the basis of an unlabelled n.m.r.-invisible pool of glutamate, our original assumption seems justified. The possibility that acid extraction results in 'release ' of peptide-bonded glutamate is thought to be unlikely. This conclusion is supported by previous reports which demonstrated that the concentration of a dipeptide, N-acetylaspartylglutamate, in neural extracts is similar whether organic solvents (Miyake et al., 1981) or PCA (Holowenko et al., 1992) are used in the extraction. Furthermore, by using the Carr-Purcell-Meiboom-Gill sequence to suppress spin-spin coupling and diffusion effects, we have previously shown (Williams et al., 1985) in severely hypoxic perfused slices that glutamate and NAA do indeed have similar intrinsic T2 values (Pirttila et al., 1993) .
It is well established that the metabolism of glutamate is compartmentalized at both intercellular (Berl et al., 1962; Van den Berg et al., 1969; Brainard et al., 1989; Cerdan et al., 1990) and subcellular (Naito and Ueda, 1983; Maycox et al., 1990; McMahon and Nicholls, 1991) levels in the brain. Experimental data suggest that the so-called small pool corresponds to glial cells and the large pool to neuronal cells. The half-life of 1 min (Berl et al., 1970) , whereas the turnover of the amino acid in the large pool is substantially slower (Van den Berg and Garfinkel, 1971; Fitzpatrick et al., 1990) . On the basis of labelling studies and enzyme distribution between individual cell types, it has been suggested that glucose is primarily metabolized in neuronal cells to glutamate, whereas exogenous acetate is converted in the first place into glutamate in glial cells which is subsequently transported to neurons as glutamine (Shank et al., 1985; Badar-Goffer et al., 1990; Cerdan et al., 1990) . As well as cellular compartmentation, glutamate is also distributed subcellularly in cytosol, mitochondria and transmitter vesicles (Naito and Ueda, 1983; Maycox et al., 1990; McMahon and Nicholls, 1991) .
Labelling of glutamate C-4 from either [1-13C]glucose or [2-'3C]acetate takes place in mitochondria. In both neuronal and glial cells, mitochondria are expected to have efficient exchange mechanisms and transporters to expel glutamate (see LaNoue and Schoolwerth, 1979) . If the labelled glutamate in the mitochondrial compartment were not detected by 'H n.m.r., then the fractional enrichment would be greater in tissue extracts than in slice preparations even if mitochondrial transport is very efficient, as, at best, this would equilibrate label in the two pools. Our data show the exact opposite; it appears that there is a pool of nonlabelled glutamate that is n.m.r.-invisible. Therefore mitochondrial glutamate must be amenable to 'H-n.m.r. detection. As the fractional enrichment from glucose of the total glutamate pool relative to the enrichment of the 'H-n.m.r.-visible pool increases with time ofincubation, we conclude that [1-13C]glucose initially labels the visible pool, which subsequently slowly exchanges label into the invisible pool.
In the early phase ofacetate superfusions, there is no significant difference between the fractional enrichments of the total pool and the 'H-n.m.r.-visible pool. This implies that acetate labels glutamate C-4 at the same rate in both the n.m.r.-visible and -invisible pools. Previous evidence points to metabolism ofacetate primarily in glial cells, whereas glucose is metabolized in both cellular pools (Badar-Goffer et al., 1990) . Therefore glutamate synthesized in glia may be partially n.m.r. invisible. However, because of the low level of fractional enrichment attained after 30 min exposure to [2-'3C]acetate, it is dangerous to place too much emphasis on this result. Given the errors in our measurements, the fractional enrichment for total glutamate would have to be less than 60% that of n.m.r.-visible glutamate for it to attain significance. At later times, when the absolute enrichment is greater, there is a significance difference between the enrichments of the total and n.m.r.-visible pools. In fact, the surest conclusion from these data is that glutamate synthesized in glia is largely (if not totally) n.m.r. visible. Therefore the invisible pool of glutamate cannot be explained on the basis of the known intercellular compartmentation, as this would require the small (glial) pool to be invisible, which the acetate data clearly exclude.
Cerebral cortex must contain a substantial pool of transmitter glutamate, as some 30 % of all cortical nerve terminals use glutamate as a neurotransmitter (McMahon and Nicholls, 1991) . It has been estimated that about one-quarter of total brain glutamate is in a neurotransmitter pool (Fonnum, 1988) . In isolated nerve terminals, transmitter glutamate which is located in vesicles, equilibrates with cytoplasmic glutamate very slowly (Wilkinson and Nicholls, 1989) . In isolated transmitter vesicles, the pH is substantially lower than in the cytoplasm because of the nature of the amino-acid-transport mechanism (Naito and Ueda, 1983) . Microenvironmental differences may affect relaxation properties and/or resonance frequency so that the pool in a different compartment becomes undetectable (Pirttila et al., glutamate in the small pool has been calculated to be approx.
1993). Our earher data showed that, after extreme energy failure (aglycaemic hypoxia), glutamate became 1000% n.m.r. visible (Kauppinen and Williams, 1991) . This would be consistent with release of glutamate from an n.m.r.-invisible pool into a fully detectable subcellular compartment.
To summarize, newly synthesized glutamate is probably almost completely visible in both neurons (labelled from glucose) and glia (labelled from glucose and acetate). Mitochondrial glutamate either must be fully visible or its steady-state concentration must be so low that its contribution to the intact slice n.m.r. spectrum is negligible. In either case, the mitochondrion cannot be the site of glutamate invisibility. We propose that the most likely explanation for glutamate n.m.r. invisibility is subcellular sequestration which may include neurotransmitter and some other pools. It is conceivable that the milieu in these compartments may alter the n.m.r. properties of glutamate via relaxation, susceptibility, metal-ion or protein-binding effects, in such a way as to render it n.m.r. invisible. Further work is required to substantiate this hypothesis. It is important to understand the factors affecting glutamate visibility, not only for its own sake, but also because it will affect the interpretation of labelling patterns and kinetics determined by 1H/13C n.m.r. (Fitzpatrick et al., 1990; Rothman et al., 1992) . The increasing use of these methods to estimate metabolic rates in vivo in animals and man emphasizes the relevance of this work.
